[Explainer] What Is The Eliminated Kickbacks In Recovery Act (Ekra) And Who Is Exposed?

#Explainer #What #Eliminated #Kickbacks #Recovery #Ekra #Exposed

Eliminating Kickbacks in Recovery Act EKRA Summary and Status by First Healthcare Compliance

Title: Eliminating Kickbacks in Recovery Act EKRA Summary and Status
Channel: First Healthcare Compliance
[How-To] How To Document The Timeline Of Discovery For Your Legal Counsel

[Explainer] What Is The Eliminated Kickbacks In Recovery Act (EKRA) And Who Is Exposed?

The healthcare landscape is heavily regulated, yet many providers and marketing professionals remain unaware of one of the most sweeping federal fraud statutes enacted in recent years: the Eliminated Kickbacks in Recovery Act (EKRA).

Enacted as part of the broader Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018, EKRA was designed to combat the opioid crisis. However, its reach extends far beyond addiction treatment centers, creating significant compliance risks for clinical laboratories, marketing agencies, and healthcare executives nationwide.

This comprehensive guide explains what EKRA is, how it differs from other healthcare fraud laws, who is most at risk of exposure, and how to ensure compliance.

What is the Eliminated Kickbacks in Recovery Act (EKRA)?

Codified under 18 U.S.C. § 220, the Eliminated Kickbacks in Recovery Act (EKRA) is a federal criminal statute that prohibits soliciting, receiving, offering, or paying any remuneration (including kickbacks, bribes, or rebates) in exchange for referring a patient to a recovery home, clinical treatment facility, or clinical laboratory.

The Origin of EKRA: Combatting the Opioid Epidemic

Before EKRA, federal prosecutors relied primarily on the Anti-Kickback Statute (AKS) to target fraudulent referral schemes. However, AKS only applies to federal healthcare programs like Medicare, Medicaid, and TRICARE.

In the mid-2010s, bad actors in the substance abuse treatment industry exploited this limitation. They engaged in "patient brokering"—selling patients with lucrative private insurance policies to sober homes and drug rehab facilities in exchange for massive kickbacks. Because these patients were privately insured, the AKS could not touch these schemes.

Congress passed EKRA to close this loophole, making patient brokering a federal crime regardless of whether the patient is covered by government or private health insurance.

How EKRA Defines Illegal Referral Schemes

Under EKRA, it is a federal crime to knowingly and willfully:

Solicit or receive any remuneration in return for referring a patient to a recovery home, clinical treatment facility, or clinical laboratory.
Offer or pay any remuneration to induce a referral to, or in exchange for individual use of, these facilities.

EKRA vs. Anti-Kickback Statute (AKS): Key Differences

While EKRA and AKS share the common goal of preventing healthcare fraud, they differ in critical ways. The most notable differences lie in their scope of payors and employment safe harbors.

| Feature | Anti-Kickback Statute (AKS) | Eliminated Kickbacks in Recovery Act (EKRA) | | :--- | :--- | :--- | | Applicable Payors | Federal healthcare programs only (Medicare, Medicaid, etc.). | All payors (Federal, state, commercial/private insurance, and self-pay). | | Targeted Entities | Any provider receiving federal healthcare funds. | Recovery homes, clinical treatment facilities, and all clinical laboratories. | | W-2 Employee Safe Harbor | Broadly permits volume- or value-based compensation for W-2 employees. | Strictly prohibits volume- or value-based compensation for W-2 employees and contractors alike. | | Penalties | Up to 10 years in prison; fines up to $100,000 per violation; exclusion from federal programs. | Up to 10 years in prison; fines up to $200,000 per violation. |

The Employment Compensation Trap

Under the AKS, healthcare businesses can legally pay their internal, W-2 sales staff commissions based on the volume or value of business they generate.

EKRA completely upends this. Under EKRA, compensation paid to employees or independent contractors cannot vary based on:

The number of individuals referred to a covered entity.
The number of tests or procedures performed.
The amount of payment/revenue generated from the referred individuals.

This means standard commission-based sales structures for laboratories and treatment centers are illegal under EKRA, even if they are perfectly legal under the AKS.

Who is Exposed Under EKRA? (The Targets)

EKRA specifically targets three types of entities, but its broad language exposes a wide range of individuals and businesses to criminal liability.

[EKRA Exposure Scope]
       │
       ├─► 1. Recovery Homes (Sober living houses, residential facilities)
       ├─► 2. Clinical Treatment Facilities (Detox, inpatient/outpatient rehab)
       ├─► 3. Clinical Laboratories (ALL labs certified under CLIA)
       └─► 4. Marketing Agencies & Sales Reps (Commission-based models)

1. Recovery Homes

Often referred to as sober living homes, these facilities provide alcohol- and drug-free living environments. Any recovery home that pays a third party or an employee to recruit residents faces severe EKRA exposure.

2. Clinical Treatment Facilities

This category includes any provider that provides detox, residential treatment, or intensive outpatient programs (IOP) for substance use disorders.

3. Clinical Laboratories (The Broadest Trap)

This is the most common area of unexpected EKRA liability. EKRA defines "laboratory" by referencing the Clinical Laboratories Improvement Amendments (CLIA).

Because of this broad definition, EKRA applies to all clinical laboratories, not just those processing toxicology or substance abuse tests.

A routine blood-testing lab, a COVID-19 testing site, or a genetic testing facility is subject to EKRA.
If a general clinical lab pays its sales representatives commissions based on the number of blood tests they bring in, that lab and the sales reps are violating EKRA—even if the tests have nothing to do with addiction recovery.

4. Healthcare Marketers and Sales Representatives

Third-party marketing agencies, lead-generation websites, and internal sales reps are highly exposed. Any marketing contract that pays "per lead," "per conversion," or a percentage of insurance payouts for a laboratory or treatment center is highly likely to be deemed an illegal kickback under EKRA.

Real-World Examples of EKRA Violations

To understand how federal prosecutors apply EKRA, consider these real-world scenarios:

Case 1: The Toxicology Lab Commission Scheme
A toxicology laboratory hires an independent marketing firm to secure drug testing contracts with local physicians. The lab pays the marketing firm a 10% commission on all insurance reimbursements generated from those doctors' referrals. Result: Both the laboratory executives and the marketing firm owners are liable under EKRA for volume-based compensation.
Case 2: The Sober Home "Patient Broker"
A sober living home pays a "call center" $1,000 for every addicted individual with private PPO insurance they successfully convince to enroll in their facility. Result: This is classic patient brokering. Both the call center operators and the sober home operators face federal prosecution under EKRA.
Case 3: The General Lab Sales Rep
A molecular laboratory pays its W-2 sales representatives a base salary plus a monthly bonus determined by the volume of cancer-screening panels ordered by the clinics they service. Result: Despite being W-2 employees, and despite the tests being for oncology rather than addiction, this compensation model violates EKRA.

Penalties for Violating EKRA

The penalties for violating EKRA are severe. Because it is a federal criminal statute, individuals face prison time, not just corporate fines.

Fines: Up to $200,000 per violation.
Imprisonment: Up to 10 years in federal prison per violation.
Joint Liability: Both the payer (the entity offering the kickback) and the recipient (the marketer, employee, or referrer) can be prosecuted.

Compliance Strategies: How to Protect Your Healthcare Business

If you operate a clinical laboratory, treatment facility, recovery home, or healthcare marketing agency, you must proactively review your business practices to ensure EKRA compliance.

1. Audit Compensation Structures Immediately

Review all contracts with sales representatives, marketing agencies, and internal business development staff.

Eliminate commission-based pay tied to the volume or value of referrals, tests, or billings.
Transition to fixed-salary or hourly compensation structures that do not fluctuate based on the volume of business generated.
If bonuses are paid, they must be based on metrics unrelated to patient referrals (e.g., hours worked, general administrative tasks, or qualitative performance reviews).

2. Implement Strict Vendor Due Diligence

If you contract with third-party marketing agencies:

Ensure agreements utilize a flat-fee model set at Fair Market Value (FMV) in advance.
Avoid "per-lead" or "percentage-of-billing" models.
Require vendors to certify in writing that they do not engage in patient brokering or illegal referral practices.

3. Conduct Regular Legal Reviews

Because EKRA is a relatively new statute, federal case law is still evolving. What was considered standard industry practice five years ago may now carry criminal liability. Work with qualified healthcare compliance counsel to conduct annual audits of your referral and marketing practices.

Summary: Staying Safe in a Highly Regulated Industry

EKRA has fundamentally changed healthcare marketing and sales compliance. By expanding federal jurisdiction to private payors and eliminating traditional W-2 commission safe harbors for laboratories and recovery facilities, the law has created a minefield for the unwary.

To protect your business and your freedom, remember this golden rule: Never pay or accept compensation that fluctuates based on the number of patients, tests, or revenue referrals bring to a laboratory, recovery home, or clinical treatment facility.

[Data Report] Average Settlement Ranges For Permanent Disability Malpractice Cases

Eliminating Kickbacks in Recovery Act EKRA and the impact on the healthcare industry by McDonald Hopkins

Title: Eliminating Kickbacks in Recovery Act EKRA and the impact on the healthcare industry
Channel: McDonald Hopkins
[Warning] Assuming You Have No Options After Receiving A Final Denial Notice

Complying With EKRA Following Recent Legal Action by Lighthouse Lab Services

Title: Complying With EKRA Following Recent Legal Action
Channel: Lighthouse Lab Services

K&L Gates Triage EKRA - New Fraud and Abuse Considerations for Clinically Integrated Networks by KLGatesLaw

Title: K&L Gates Triage EKRA - New Fraud and Abuse Considerations for Clinically Integrated Networks
Channel: KLGatesLaw